Literature DB >> 11976403

Release of cytokines by human nasal epithelial cells and peripheral blood mononuclear cells infected with Mycoplasma pneumoniae.

Mikhail Y Kazachkov1, P C Hu, Johnny L Carson, Paula C Murphy, Frederick W Henderson, Terry L Noah.   

Abstract

Mycoplasma pneumoniae (Mp) infection is associated with asthma exacerbation in children. We hypothesized that Mp infection may cause airway inflammation by inducing the release of cytokines by respiratory epithelial cells. The levels of chemokines interleukin-8 (IL-8) and released upon activation, normal t cell expressed and secreted (RANTES) released by nasal epithelial cell (NEC) cultures established from asthmatic and nonasthmatic children were measured by ELISA at 4, 24, 48, and 72 hr after cells were inoculated with Mp, and were compared with baseline release of these factors. The presence of MP on apical membranes of NEC after infection was confirmed by transmission electron microscopy, and adherence was shown to be inhibited by erythromycin. Mp infection did not alter NEC release of IL-8 or RANTES at any time point. In contrast, tumor necrosis factor alpha (TNF-alpha) stimulated increased IL-8 at all time points, and respiratory syncytial virus (RSV) infection stimulated RANTES release at 48 and 72 hr by NEC. These results were not significantly different between NEC from asthmatic and nonasthmatic children. As a comparison, peripheral blood mononuclear cells from normal human volunteers were also incubated with Mp and had significantly increased release of IL-2, IL-6, and TNF-alpha. We conclude that Mp, unlike viral pathogens such as RSV, is unlikely to directly stimulate early airway surface cytokine responses via mechanisms involving epithelial cells. We speculate that the chronic presence of mononuclear cells at the airway surface of asthmatics provides a target for Mp-triggered cytokine production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976403     DOI: 10.1177/153537020222700505

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  8 in total

1.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

2.  Hepatocyte growth factor can guide treatment of Mycoplasma pneumoniae pneumonia in children.

Authors:  Lun Qin Liu; Zhi Hua Wang; Hai Yun Yao
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

3.  Inhibition of message for FcepsilonRI alpha chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae.

Authors:  Danlin Luo; Yuling Dai; Lynn B Duffy; T Prescott Atkinson
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

4.  The Role of Mycoplasma pneumoniae Infection in Asthma.

Authors:  Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2012-02-21       Impact factor: 5.764

5.  Melatonin promoted chemotaxins expression in lung epithelial cell stimulated with TNF-alpha.

Authors:  FengMing Luo; XiaoJing Liu; ShuangQing Li; ChunTao Liu; ZengLi Wang
Journal:  Respir Res       Date:  2004-11-10

6.  High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia.

Authors:  Ying Ding; Chu Chu; Yuqin Li; Gen Li; Xiaoli Lei; Weifang Zhou; Zhengrong Chen
Journal:  BMC Infect Dis       Date:  2018-08-29       Impact factor: 3.090

7.  Quantification of mRNA encoding cytokines and chemokines and assessment of ciliary function in canine tracheal epithelium during infection with canine respiratory coronavirus (CRCoV).

Authors:  Simon L Priestnall; Judy A Mitchell; Harriet W Brooks; Joe Brownlie; Kerstin Erles
Journal:  Vet Immunol Immunopathol       Date:  2008-09-27       Impact factor: 2.046

8.  The critical function of miR-1323/Il6 axis in children with Mycoplasma pneumoniae pneumonia.

Authors:  Linlin Yin; Yajun Ma; Wenlong Wang; Yitang Zhu
Journal:  J Pediatr (Rio J)       Date:  2020-12-19       Impact factor: 2.990

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.